Tienoxolol

Drug Profile

Tienoxolol

Alternative Names: UP 78842

Latest Information Update: 21 Nov 2007

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator UPSA
  • Class Anti-ischaemics; Antihypertensives; Benzoic acids
  • Mechanism of Action Beta-adrenergic receptor antagonists; Diuretics
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Hypertension; Ischaemic heart disorders

Most Recent Events

  • 23 Sep 1997 No-Development-Reported for Hypertension in Belgium (Unknown route)
  • 23 Sep 1997 No-Development-Reported for Hypertension in France (Unknown route)
  • 23 Sep 1997 No-Development-Reported for Hypertension in Germany (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top